APAC Rheumatoid Arthritis Therapeutics Market Analysis


  • Type: Common Disease Area
  • Published : February 2022
  • Region: APAC
  • Country: Other
  • Report ID : 5053

  • Format: PPT, PDF

APAC Rheumatoid Arthritis Therapeutics Market Analysis: Segmented by Indication, Drug Class, Treatment, and Country – Growth, Market Size, Future Prospects & Competitive Analysis, 2018 – 2023

SKU: 5053 Categories: ,

Report Description of the APAC Rheumatoid Arthritis Therapeutics Market

Research Scope and Assumption

  • The report provides the market value for the base year 2020 and a yearly forecast up to 2028 in terms of revenue (USD billion)
  • The key industry dynamics, regulatory scenario, reimbursement scenario, major market trends, and drug markets are evaluated to understand their impacts on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis
  • We have used the combination of top-down and bottom-up approach for market sizing, analyzing key regional markets, dynamics, and trends for various solutions, services, and end uses
  • All market estimates and forecasts have been validated through primary interviews with the Key Industry Players (KIPs) and secondary analysis
  • Inflation has not been accounted for in order to estimate and forecast the market
  • Numbers may not add up due to rounding off

Reason to buy the report:

  • Facilitate decision-making based on strong current and forecast data for APAC Rheumatoid Arthritis Therapeutics Drug Market
  • Develop strategies based on the latest regulatory framework
  • Strategically analyze micro-markets with respect to individual growth trends, future prospects, and their contribution to the market
  • Analyze competitive developments such as expansions, investments, mergers & acquisitions, new product developments, and research & developments in the Migraine Drug market
  • Analyze the opportunities in the market for stakeholders and draw a competitive landscape for market leaders
  • To strategically profile key players and comprehensively analyze their market shares and core competencies
  • We have technically sound team which do a deep dive research and also provide strategy based consulting analysis

APAC Rheumatoid Arthritis Therapeutics Drugs Market Executive Summary

Rheumatoid Arthritis (RA) is a chronic, progressive, and currently incurable autoimmune disease that primarily affects the joints. It is characterized by synovial inflammation and gradual bone erosion over many years. Moreover, surge in focus of leading manufacturers on expanding their geographical presence in emerging Asia-Pacific countries to capture high rheumatoid arthritis drugs market share is expected to drive the growth of the market in the region.

Market Size and Key Findings

The APAC Rheumatoid Arthritis Therapeutics Market size stood at around USD 5.6 billion in 2018 and is projected to reach USD 9.5 billion by 2023, exhibiting a CAGR of 8% during the forecast period.

The RA therapeutic market has become very competitive due to the high number of new drug approvals. Competition is fierce, particularly among TNFa inhibitors, which dominate the treatment market for RA patients who are refractory to traditional disease-modifying antirheumatic drugs (DMARD). Despite this, 30% of RA patients fail to attain a clinical response when treated with TNFa inhibitors. However, other targeted programs, as well as newly marketed small-molecule DMARDs such as the Janus kinase (JAK)I nhibitor Xeljanz (tofacitinib), have the potential to replace ineffective TNFa inhibitors.

Market Dynamics

Market Growth Drivers Analysis

Owing to the presence of large population base susceptible to rheumatoid arthritis, increase in public awareness toward use & benefits of these drugs, the development of the R&D sector, rise in healthcare reforms, and an increase in the adoption of rheumatoid arthritis drugs. Moreover, increase in demand for DMARDs and rise in the geriatric population contribute toward growth of the market.

Market Restraints

Side effects associated with the medication and high costs of biological DMARD therapies are expected to act as the key restraints of the global market.

Competitive Landscape

Key Players

The key companies operating in the market include Pfizer Inc., AbbVie Inc., Johnson & Johnson, GlaxoSmithKline plc, Merck & Co., Inc., Novartis AG, F. Hoffmann-La Roche AG, Eli Lily and Company, AstraZeneca PLC, and Amgen Inc.

Products in Pipeline

Few pipeline Agents include one GM-CSF-inhibiting biologic (GSK’s otilimab), one IL-6-inhibiting biologic (R-Pharm’s olokizumab), one TNF-inhibiting biologic (Taisho’s ozoralizumab), one BTK inhibitor (Roche/Genentech’s fenebrutinib), and one IRAK 4 inhibitor (Pfizer’s PF-06650833).

Notable Recent Deals

Recently, Elli Lilly, a US-based major pharmaceutical company, has entered into licensing agreements with a number of Indian drug manufacturers for the manufacture of and supply of Baricitinib in India which is showing promise as a drug for the treatment of Covid-19.The licensing agreement with Eli Lilly is voluntary, royalty-free, and non-exclusive in nature for the manufacture and commercialization of the drug in India

Healthcare Policies and Regulatory Landscape

Pricing and Reimbursement scenario of APAC Rheumatoid Arthritis Therapy

Pfizer China announced today that it has received approval from the Chinese Food and Drug Administration (CFDA) to market its oral Janus kinase (JAK) inhibitor, XELJANZ® (tofacitinib citrate), in China for the treatment of adult patients with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response or intolerance to methotrexate (MTX). It may be used in combination with MTX or other non-biologic disease-modifying antirheumatic drugs (DMARDs).

1. Report Description of the APAC Rheumatoid Arthritis Therapeutics Market
1.1 Research Scope and Assumption
1.2 Objective of the study
1.3 Research Methodology
1.4 Reason to buy the report
2. APAC Rheumatoid Arthritis Therapeutics Market Executive Summary
2.1. APAC Rheumatoid Arthritis Therapeutics Market – Industry Snapshot & key buying criteria, 2018-2023
2.2. Market Size, Growth Prospects and Key findings
3. Market Dynamics of APAC Rheumatoid Arthritis Therapeutics market
3.1. Market Growth Drivers Analysis
3.1.1. large population base susceptible to rheumatoid arthritis
3.1.2. Increase in public awareness toward use & benefits of these drugs
3.1.3. The development of the R&D sector
3.1.4. Rise in healthcare reforms
3.1.5. Increase in the adoption of rheumatoid arthritis drugs
3.1.6. Rise in the geriatric population
3.1.7. Increase in demand for DMARDs
3.2. Market Restraints Analysis
3.2.1. Side-effects Associated with Rheumatoid Arthritis Medications
3.2.2. High costs of biological DMARD therapies
4. APAC Rheumatoid Arthritis Therapeutics Market Segmentation
4.1. By Indication Type Analysis:
4.1.1. Arthritis
4.1.2. Respiratory Disease
4.1.3. Psoriasis
4.1.4. Inflammatory Bowel Disease (IBD)
4.1.5. Other Inflammatory diseases
4.2. By Drug Class Type Analysis:
4.2.1. Nonsteroidal Anti-Inflammatory Diseases (NSAIDs)
4.2.2. Corticosteroids
4.2.3. Biologics
4.2.4. Immune Selective Anti-Inflammatory Derivatives (ImSAIDs)
4.3. By Country Analysis:
4.3.1. Japan
4.3.2. China
4.3.3. India
4.3.4. Australia
4.3.5. South Korea
4.3.6. Indonesia
4.3.7. Other APAC countries
5. APAC Rheumatoid Arthritis Therapeutics Major Products Market Share
5.1 Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape
6.1. Major Top Market Players
6.2. Products in Pipeline
6.3. R&D Initiatives in APAC Rheumatoid Arthritis Therapeutics Market
6.4. Notable recent deals in APAC Rheumatoid Arthritis Therapeutics Market
6.4.1. Joint Ventures
6.4.2. Partnerships
6.4.3. Mergers & Acquisitions
6.4.4. Strategic divestments
7. Key Company Profiles
7.1. Pfizer Inc. Company overview
Product & Services, Strategies & Financials
7.2. AbbVie Inc.Company overview
Product & Services, Strategies & Financials
7.3. Johnson & Johnson Company overview
Product & Services, Strategies & Financials
7.4. GlaxoSmithKline plc Company overview
Product & Services, Strategies & Financials
7.5. Merck & Co., Inc.Company overview
Product & Services, Strategies & Financials
7.6. Novartis AG Company overview
Product & Services, Strategies & Financials
7.7. F. Hoffmann-La Roche AG Company overview
Product & Services, Strategies & Financials
7.8. Eli Lily and Company Company overview
Product & Services, Strategies & Financials
7.9. Amgen, Inc.
Product & Services, Strategies & Financials
7.10. AstraZeneca PLC
Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape
8.1. Pricing and Reimbursement scenario
8.2. Government Initiatives / Intervention programs
9. Factors Driving Future Growth
9.1. New Trends and Development of Rheumatoid Arthritis Therapeutics Market
9.2. Future Opportunities
10. Strategic Recommendations

Rheumatoid Arthritis Therapeutics Market Segmentation

By Indication Type:

Based on the indication type the APAC Rheumatoid Arthritis Market is sub-segmented into Arthritis, Respiratory disease, Psoriasis, Inflammatory Bowel Disease, and other inflammatory diseases.

  • Arthritis
    • Rheumatoid Arthritis
    • Osteoarthritis
    • Ankylosing Spondylitis
    • Psoriatic ArthritisGout
  • Respiratory Disease
    • Asthma
    • Chronic Obstructive Pulmonary Diseases (COPD)
  • Psoriasis
  • Inflammatory Bowel Disease (IBD)
    • Crohn’s disease
    • Ulcerative Colitis
  • Other Inflammatory diseases

By Drug Class:

Based on the Drug class APAC Rheumatoid Arthritis Market is sub-segmented into-

  • Nonsteroidal Anti-Inflammatory Diseases (NSAIDs)
  • Corticosteroids
  • Biologics
  • Immune Selective Anti-Inflammatory Derivatives (ImSAIDs)

By Country:

Based On country APAC Rheumatoid Arthritis market is sub-segmented into-

  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Indonesia
  • Other APAC countries

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements